MYNZ
Mainz Biomed BV
NASDAQ: MYNZ · HEALTHCARE · DIAGNOSTICS & RESEARCH
$0.41
-3.73% today
Updated 2026-05-01
Market cap
$7.90M
P/E ratio
—
P/S ratio
16.01x
EPS (TTM)
$-5.28
Dividend yield
—
52W range
$1 – $5
Volume
0.8M
WallStSmart proprietary scores
18
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C4.0
Quality
C2.5
Profitability
F4.0
Valuation
C6/9
Piotroski F-Score
Moderate
-14.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$14.00
+3309.64%
12-Month target
—
—
Intrinsic (DCF)
$0.52
Margin of safety
-62.85%
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Altman Z -14.01 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-6.52M
- Revenue declining -0.45% QoQ
- 62.85% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $577348.00 | $529877.00 | $895479.00 | $893991.00 | $659940.00 |
| Net income | $-11.69M | $-26.45M | $-26.30M | $-21.65M | $-8.34M |
| EPS | — | — | — | — | $-5.28 |
| Free cash flow | $-3.24M | $-15.43M | $-23.84M | $-17.34M | $-6.52M |
| Profit margin | -2,024.79% | -4,992.24% | -2,936.50% | -2,421.80% | — |
Peer comparison
Smart narrative
Mainz Biomed BV trades at $0.41. Our Smart Value Score of 18/100 indicates the stock is weak. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of -14.01, it sits in the distress. TTM revenue stands at $659940.00. Our DCF model estimates intrinsic value at $0.52.
Frequently asked questions
What is Mainz Biomed BV's stock price?
Mainz Biomed BV (MYNZ) trades at $0.41.
Is Mainz Biomed BV overvalued?
Smart Value Score 18/100 (Grade F, Strong Sell). DCF value $0.52.
What is the price target of Mainz Biomed BV (MYNZ)?
The analyst target price is $14.00, representing +3309.6% upside from the current price of $0.41.
What is the intrinsic value of Mainz Biomed BV (MYNZ)?
Based on our DCF model, intrinsic value is $0.52, a -62.9% margin of safety versus $0.41.
What is Mainz Biomed BV's revenue?
TTM revenue is $659940.00.
Piotroski F-Score?
6/9 — moderate financial health.
Altman Z-Score?
-14.01 — distress.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio16.01x
ROE-4.66%
Beta0.26
50D MA$1.55
200D MA$2.71
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—